000 01413 a2200433 4500
005 20250515175824.0
264 0 _c20091013
008 200910s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2009.06.041
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElliot, David
245 0 0 _aNovel inhibitors of the alphavbeta3 integrin--lead identification strategy.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cAug 2009
300 _a4832-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBinding Sites
650 0 4 _aComputer Simulation
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aIntegrin alphaVbeta3
_xantagonists & inhibitors
650 0 4 _aOligopeptides
_xchemistry
650 0 4 _aRats
650 0 4 _aSmall Molecule Libraries
650 0 4 _aStructure-Activity Relationship
700 1 _aHenshaw, Eleanor
700 1 _aMacFaul, Philip A
700 1 _aMorley, Andrew D
700 1 _aNewham, Peter
700 1 _aOldham, Keith
700 1 _aPage, Ken
700 1 _aRankine, Neil
700 1 _aSharpe, Paul
700 1 _aTing, Attilla
700 1 _aWood, Christine M
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 19
_gno. 16
_gp. 4832-5
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2009.06.041
_zAvailable from publisher's website
999 _c18990150
_d18990150